Dinutuximab
NANT 2013-01
Phase 1 small_molecule active
Quick answer
Dinutuximab for Neuroblastoma is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 2 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Neuroblastoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active